Curcumin May Reduce the Risk of Breast Cancer in Women Who Have Used HRT

It is known that horse urine estrogen and synthetic progesterone Steroid hormone produced in ovaries and adrenal glands that is involved with female menstrual cycle, pregnancy, and embyro development. (medroxyprogesterone acetate) increase the risk of later breast cancer.  A new animal study shows that curcumin¹ can prevent changes in breast tissue from exposure to these drugs that otherwise increases cancer risk.

Six million women continue to use these dangerous drugs to manage their menopausal symptoms and many women have used them in the past and already induced changes in their breast tissue that are problematic.

In the animal experiment curcumin delayed the onset of breast cancer in rats exposed to these toxic drugs, down regulates the cancer growth factor in breast tissue that these drugs release (vascular endothelial growth factor), and prevented multiple other adverse changes in breast tissue.  Curcumin did not lower or metabolize the surplus drug levels of estrogen or progesterone Steroid hormone produced in ovaries and adrenal glands that is involved with female menstrual cycle, pregnancy, and embyro development., indicating that its role was one of direct protection of breast tissue.

This is very good news for women who have taken HRT in the past or are currently taking these hormone replacement drugs.